Language selection

Search

2017-12-29 - Female - 22 Years old

707252

Adverse reaction report number 707252
Latest AER version number 0
Market authorization holder AER number N/A
Initial received date 2017-12-29
Latest received date 2017-12-29
Age 22 Years
Gender Female
Weight N/A
Type of report Spontaneous
Reporter type Other Health Professional
Source of report Community
Report outcome Unknown
Serious report? No

Product information

Product description Dosage form Health product role Route of administration Dose Frequency Therapy duration Indication(s)
ADDERALL XR 20MGCAPSULE, EXTENDED RELEASESuspect20 Milligram1 every 1 Day(s) Attention deficit/hyperactivity disorder

Adverse reaction term information

MedDRA version: v.21.1
Adverse reaction terms Reaction duration
Headache
Insomnia
Nausea
Date modified: